The decision on the Excellence Award winner is made by the Award Committee, consisting of seven members: Ronald Seeliger, CEO of Hemofarm Group, Veran Matić, Chairman of B92 Foundation and Chairman of the Excellence Award Committee, Vigor Majić, Director of Petnica Research Centre and the first laureate of the Excellence Award, Prof. Svetozar Putnik, Director of Cardiac Surgery Clinic of the Clinical Centre of Serbia, Prof. Vera Artiko, Director of the Nuclear Medicine Centre of the Clinical Centre of Serbia, Dr Đorđija Petkoski, Lecturer at the Wharton School of the University of Pennsylvania and a consultant of the World Bank, and Nikola Ivica, a doctoral student of biology at MIT University.
You can find the biographies of the members of the Excellence Award Committee if you click
HERE.
The Committee decides on the winner based on the received proposals, in the field of health, education and culture. This will additionally affirm individuals, groups, organisations, institutions, and their projects which change the society of the better. The following applicants from the territory of the Republic of Serbia are entitled to submit award proposals: members of the Serbian Academy of Sciences and Arts, members of the Serbian Medical Association, professional scientists and/or university teachers, directors of institutes, directors of public and other healthcare, educational, and cultural institutions, directors of clinical hospital centres in Belgrade, Novi Sad, Niš, and Kragujevac, patients’ associations, civil society (organisations, funds and foundations), as well as directors and editors-in-chief of public media.
The members of the Committee are also entitled to submit award proposals themselves in case the already submitted proposals do not meet the established criteria and standards. The Committee passes a decision on the annual award based on the submitted proposals and based on their own assessment and judgement. The deadline for submitting proposals is 1 March of the current calendar year. The process of evaluation of the received proposals by the Award Committee lasts until 30 April of the current calendar year, while the ceremony of announcing the names of winners and presenting the annual award takes place in May of the current year.
Due to the coronavirus pandemic, the deadline for submitting nominations for the 2020 Excellence Award was extended until 1 September 2020, and the laureate was announced on 3 December 2020.
Ronald Seeliger, CEO of Hemofarm Group, Veran Matić, Chairman of B92 Foundation and Chairman of the Excellence Award Committee, Vigor Majić, Director of Petnica Research Centre and the first laureate of the Excellence Award, Prof. Svetozar Putnik, Director of Cardiac Surgery Clinic of the Clinical Centre of Serbia, Prof. Vera Artiko, Director of the Nuclear Medicine Centre of the Clinical Centre of Serbia, Dr Đorđija Petkoski, Lecturer at the Wharton School of the University of Pennsylvania and a consultant of the World Bank, and Nikola Ivica, a doctoral student of biology at MIT University.